Mitochondria in Alzheimer's disease

International Review of Neurobiology

Volumn 53, Issue , 2002, Pages 341-385

  Swerdlow, Russell H ^a   Kish, Stephen J ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

ALZHEIMER DISEASE; BRAIN; CYTOCHROME C OXIDASE DEFICIENCY; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; REVIEW;

ALZHEIMER DISEASE; BRAIN; CYTOCHROME-C OXIDASE DEFICIENCY; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; KETOGLUTARATE DEHYDROGENASE COMPLEX; MITOCHONDRIA; PYRUVATE DEHYDROGENASE COMPLEX;

EID: 0036982389     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7742(02)53013-0     Document Type: Review

References (185)

1. M.Y. Aksenov H.M. Tucker P. Nair M.V. Aksenova D.A. Butterfield S. Estus W.R. Markesbery The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease Neurochem. Res. 24 1999 767 774
2. A. Alzheimer Uber eine eigenartige Erkrankung der Hirnrinde Allg. Z. Psychiatr. Psych-Gerichtl. Med. 64 1907 146 148
3. S. Anderson A.T. Bankier B.G. Barrell M.H. de Bruijn A.R. Coulson J. Drouin I.C. Eperon D.P. Nierlich B.A. Roe F. Sanger P.H. Schreier A.J. Smith R. Staden I.G. Young Sequence and organization of the human mitochondrial genome Nature 290 1981 457 465
4. V. Askanas J. McFerrin S. Baque R.B. Alvarez E. Sarkozi W.K. Engel Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle Proc. Natl. Acad. Sci. USA 93 1996 1314 1319
5. N. Barroso Y. Campos R. Huertas J. Esteban J.A. Molina A. Alonso E. Gutierrez-Rivas J. Arenas Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease Clin. Chem. 39 1993 667 669
6. M.F. Beal Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31 1992 119 130
7. K.B. Beckman B.N. Ames Mitochondrial aging: Open questions Ann. N.Y. Acad. Sci. 854 1998 118 127
8. M.C. Bennett D.M. Diamond S.L. Stryker J.K. Parks W.D. Parker Jr. Cytochrome oxidase inhibition: A novel animal model of Alzheimer's disease J. Geriatr Psychiatry Neural. 5 1992 93 101
9. M.C. Bennett G.M. Rose Chronic sodium azide treatment impairs learning of the Morris water maze task Behav. Neural Biol. 58 1992 72 75
10. M.C. Bennett G.W. Mlady Y.H. Kwon G.M. Rose Chronic in vivo sodium azide infusion induces selective and stable inhibition of cytochrome c oxidase J. Neurochem. 66 1996 2606 2611
11. G.E. Berrios Alzheimer's disease: A conceptual History Int. J. Geriatr Psychiatry 5 1990 355 365
12. L. Bianchi A Textbook of Psychiatry 1906 Balliere, Tindall and Cox London
13. G.N. Bijur R.E. Davis R.S. Jope Rapid activation of heat shock factor-1 DNA binding by H202 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells Brain Res. Mol. Brain Res. 71 1999 69 77
14. B.J. Blanchard T. Park W.J. Fripp L.S. Lerman V.M. Ingram A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue Neuroreport 4 1993 799 802
15. J.P. Blass A. Zemcov Alzheimer's disease: A metabolic systems degeneration? Neurochem. Pathol. 2 1984 103 114
16. J.P. Blass A.C. Baker L. Ko R.S. Black Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation Arch. Neurol. 47 1990 864 869
17. J.P. Blass G.E. Gibson The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease Rev. Neurol. 147 1991 513 525
18. E. Bonilla K. Tanji M. Hirano T.H. Vu S. DiMauro E.A. Schon Mitochondrial involvement in Alzheimer's disease Biochim. Biophys. Acta 1410 1999 171 182
19. I.W. Borowsky R.C. Collins Histochemical changes in enzymes of energy metabolism in the dentate gyrus accompany deafferentation and synaptic reorganization Neuroscience 33 1989 253 262
20. F. Bosetti F. Brizzi S. Barogi M. Mancuso G. Siciliano E.A. Tendi L. Murri S.I. Rapoport G. Solaini Cytochrome c oxidase and mitochondrial FIFO-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol. Aging 23 2002 371 376
21. D.M. Bowen P. White J.A. Spillane M.J. Goodhardt G. Curzon P. Iwangoff W. MeierRuge A.N. Davison Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1 1979 11 14
22. M.D. Brown J.M. Shoffner Y.L. Kim A.S. Jun B.H. Graham M.F. Cabell D.S. Gurley D.C. Wallace Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients Am. J. Med. Genet. 61 1996 283 289
23. A.M. Brown R.K. Shen R. Mohs V. Haroutunian J.P. Blass Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA) J. Mol. Neurosci. 16 2001 41 48
24. C.L. Bunn D.C. Wallace J.M. Eisenstadt Cytoplasmic inheritance of chloramphenicol resistance in mouse tissue culture cells Proc. Natl. Acad. Sci. USA 71 1974 1681 1685
25. M.L. Bush J.S. Miyashiro V.M. Ingram Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells Proc. Natl. Acad. Sci. USA 92 1995 1861 1865
26. R.F. Butterworth A.M. Besnard Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease Metab. Brain Dis. 5 1990 179 184
27. L. Canevari J.B. Clark T.E. Bates β-Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria FEBS Lett. 457 1999 131 134
28. S.M. Cardoso M.T. Proenca S. Santos I. Santana C.R. Oliviera A possible mechanism for the decrease of cytochrome oxidase in Alzheimer's disease Soc. Neurosci. Abstr. 25 1999 337
29. D.S. Cassarino R.H. Swerdlow J.K. Parks W.D. Parker Jr. J.P. Bennett Jr. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids Biochem. Biophys. Res. Commun. 248 1998 168 173
30. L. Cavelier E.E. Jazin I. Eriksson J. Prince U. Bave L. Oreland U. Gyllensten Decreased cytochromec oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics Genomics 29 1995 217 224
31. P. Chagnon C. Betard Y. Robitaille A. Cholette D. Gauvreau Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases Neuroreport 6 1995 711 715
32. P. Chagnon M. Gee M. Filion Y. Robitaille M. Belouchi D. Gauvreau Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population Am. J. Med. Genet. 85 1999 20 30
33. K. Chandrasekaran J. Stoll D.R. Brady S.I. Rapoport Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex of the monkey brain: Correlation with specific neuronal pathways Brain Res. 579 1992 333 336
34. K. Chandrasekaran J. Stoll T. Giordano J.R. Atack M.F. Matocha D.R. Brady S.I. Rapoport Differential expression of cytochrome oxidase (COX) genes in different regions of monkey brain J. Neurosci. Res. 32 1992 415 423
35. K. Chandrasekaran T. Giordano D.R. Brady J. Stoll L.J. Martin S.I. Rapoport Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease Brain Res. Mol. Brain Res. 24 1994 336 340
36. K. Chandrasekaran K. Hatanpaa D.R. Brady S.I. Rapoport Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease Exp. Neurol. 142 1996 80 88
37. K. Chandrasekaran K. Hatanpaa S.I. Rapoport D.R. Brady Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease Brain Res. Mol. Brain Res. 44 1997 99 104
38. K. Chandrasekaran K. Hatanpaa D.R. Brady J. Stoll S.I. Rapoport Downregulation of oxidative phosphorylation in Alzheimer disease: Loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex Brain Res. 796 1998 13 19
39. S.W. Chang D. Zhang H.D. Chung H.P. Zassenhaus The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain Biochem. Biophys. Res. Commun. 273 2000 203 208
40. P.F. Chinnery G.A. Taylor N. Howell R.M. Andews C.M. Morris R.W. Taylor I.G. McKeith R.H. Perry J.A. Edwardson D.M. Turnbull Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies Neurology 55 2000 302 304
41. A. Chomyn S.T. Lai R. Shakeley N. Bresolin G. Scarlato G. Attardi Platelet-mediated transformation of mtDNA-less human cells: Analysis of phenotypic variability among clones from normal individuals—and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers Am. J. Hum. Genet. 54 1994 966 974
42. J.M. Cooper C. Wischik A.H.V. Schapira Mitochondrial function in Alzheimer's disease Lancet 341 1993 969 970
43. M. Corral-Debrinski T. Horton M.T. Lott J.M. Shoffner A.C. McKee M.F. Beal B.H. Graham D.C. Wallace Marked changes in mitochondrial DNA deletion levels in Alzheimer brains Genomics 23 1994 471 476
44. D.A. Cottrell E.L. Blakely M.A. Johnson P.G. Ince D.M. Turnbull Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD Neurology 57 2001 260 264
45. D. Curti F. Rognoni L. Gasparini A. Cattaneo M. Paolillo M. Racchi L. Zani A. Bianchetti M. Trabucchi S. Bergamaschi S. Govoni Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients Neurosci. Lett. 236 1997 13 16
46. R.E. Davis S. Miller C. Herrnstadt S.S. Ghosh E. Fahy L.A. Shinobu D. Galasko L.J. Thal M.F. Beal N. Howell W.D. Parker Jr. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease Proc. Natl. Acad. Sci. USA 94 1997 4526 4531
47. R.E. Davis S. Miller C. Herrnstadt C. Ghosh E. Fahy L.A. Shinobu D. Galasko L.J. Thal M.F. Beal N. Howell W.D. Parker Jr. Proc. Nat. Acad. Sci. USA 95 1998 12069
48. J.N. Davis 2nd W.D. Parker Jr. Evidence that two reports of mtDNA cytochrome c oxidase “mutations” in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin Biochem. Biophys. Res. Commun. 244 1998 8778 8783
49. J.N. Davis 2nd J.C. Chisholm Alois Alzheimer and the amyloid debate Nature 400 1999 810
50. S.M. de La Monte T.R. Neely J. Cannon J.R. Wands Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons Cell. Mol. Life Sci. 57 2000 1471 1481
51. S.M. de La Monte T. Luong T.R. Neely D. Robinson J.R. Wands Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease Lab. Invest. 80 2000 1323 1335
52. F. De Sarno G.N. Bijur R. Lu R.E. Davis R.S. Jope Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells Neurobiol. Aging 21 2000 31 38
53. P. Desjardins J.M. de Muys R. Morais An established avian fibroblast cell line without mitochondrial DNA Somat. Cell Mol. Genet. 12 1986 133 139
54. R. Duara R.F. Lopez-Alberola W.W. Barker D.A. Loewenstein M. Zatinsky C.E. Eisdorfer G.B. Weinberg A comparison of familial and sporadic Alzheimer's disease Neurology 43 1993 1377 1384
55. K. Duff Transgenic mouse models of Alzheimer's disease: Phenotype and mechanisms of pathogenesis Biochem. Soc. Symp. 67 2001 195 202
56. S.D. Edland J.M. Silverman E.R. Peskind D. Tsuang E. Wijsman J.C. Morris Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance Neurology 47 1996 254 256
57. S.D. Edland M.J. Rieder M. Poot W.A. Kukull F.S. Rabinovich G.M. Martin D.A. Nickerson Mitochondrial genetic variants and Alzheimer's disease: Whole genome sequencing of ten pedigrees with a matrilineal pattern of inheritance Neurology 52 1999 A251
58. S.D. Edland V.O. Tobe M.J. Rieder J.D. Bowen W. McCormick L. Teri G.D. Schellenberg E.B. Larson D.A. Nickerson W.A. Kukull Mitochondrial genetic variants and Alzheimer disease: A case-control study of the T4336C and G5460A variants Alzheimer Dis. Assoc. Disord. 16 2002 1 7
59. D. Ehrenkrantz J.M. Silverman C.J. Smith S. Birstein D. Marin R.C. Mohs K.L. Davis Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease Am. J. Med. Genet. 88 1999 378 382
60. R. Egensperger S. Kosel N.M. Schnopp P. Mehraein M.B. Graeber Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases Neuropathol. Appl. Neurobiol. 23 1997 315 321
61. B. Ephrussi H. Hottinger A.M. Chimenes Action de l'acriflavine sur les levures, I: la mutation “petite clonie” Ann. Inst. Pasteur 76 1949 531
62. D.A. Evans H.H. Funkenstein M.S. Albert P.A. Scherr N.R. Cook M.J. Chown L.E. Hebert C.H. Hennekens J.O. Taylor Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported JAMA 262 1989 2551 2556
63. S.H. Ferris M.J. de Leon A.P. Wolf T. Farkas D.R. Christman B. Reisberg J.S. Fowler R. MacGregor A. Goldman A.E. George S. Rampal Positron emission tomography in the study of aginag ans senile dementia Neurobio. Aging 1 1980 127 131
64. N.L. Foster T.N. Chase P. Fedio N.J. Patronas R.A. Brooks G. DiChiro Alzheimer's disease: Focal cortical changes shown by positron emission tomography Neurology 33 1983 961 965
65. R.S.J. Frackowiack C. Pozzilli N.J. Legg G.H. DuBoulay J. Marchall G.L. Lenzi T. Jones Regional cerebral oxygen supply and utilization in dementiaA clinical and physiological study with oxygen-15 and positron tomography Brain 104 1981 753 778
66. R.I. Friede Enzyme histochemical studies of senile plaques J. Neuropathol. Exp. Neurol. 24 1965 477 491
67. R.P. Friedland T.F. Budinger E. Ganz Y. Yano C.A. Mathis B. Koss B.A. Ober R.H. Huesman S.E. Derenzo Regional cerebral metabolic alterations in dementia of the Alzheimer-type: Positron emission tomographywith (18F) fluorodeoxyglucose J. Comput. Assist. Tomogr. 7 1983 590 598
68. R. Fukuyama K. Hatanpaa S.I. Rapoport K. Chandrasekaran Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients Brain Res. 713 1996 290 293
69. D. Gabuzda J. Busciglio L.B. Chen P. Matsudaira B.A. Yankner Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative J. Biol. Chem. 269 1994 13623 13628
70. G.E. Gibson K.F. Shen J.P. Blass A. Baker K.C. Carlson B. Harding P. Perrino Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease Arch. Neurol. 45 1988 836 840
71. G.G. Glenner C.W. Wong Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120 1984 885 890
72. A. Goate M.C. Chartier-Harlin M. Mullan J. Brown F. Crawford L. Fidani L. Giuffra A. Haynes N. Irving L. James Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706
73. D. Goldgaber M.I. Lerman O.W. McBride U. Saffiotti D.C. Gajdusek Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease Science 235 1987 877 880
74. F. Gonzalez-Lima J. Valla S. Matos-Collazo Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients Brain Res. 752 1997 117 126
75. M.B. Graeber S. Kosel R. Egensperger R.B. Banati U. Muller K. Bise E. Hoff H.J. Moller K. Fujisawa E. Mehraein Rediscovery of the case described by Alois Alzheimer in 1911: Historical, histological and molecular genetic analysis Neurogenetics 1 1997 73 80
76. N.S. Hamblet F.J. Castora Elevated levels of the Kearns-Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer's patients Mutat. Res. 379 1997 253 262
77. J. Hardy D. Allsop Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends Pharmacol. Sci. 12 1991 383 388
78. J.A. Hardy G.A. Higgins Alzheimer's disease: The amyloid cascade hypothesis Science 256 1992 184 185
79. K. Hardy Amyloid, the presenilins and Alzheimer's disease Trends Neurosci. 20 1997 154 159
80. K. Hatanpaa D.R. Brady J. Stoll S.L. Rapoport K. Chandrasekaran Neuronal activity and early neurofibrillary tangles in Alzheimer's disease Ann. Neurol. 40 1996 411 420
81. K. Hatanpaa K. Chandrasekaran D.R. Brady S.I. Rapoport No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism Brain Res. Mol. Brain Res. 59 1998 13 21
82. J.V. Haxby C.L. Grady R.P. Friedland S.I. Rapoport Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: Longitudinal confirmation. J. Neural. Transm. Suppl. 24 1986 49 53
83. K. Hirai G. Aliev A. Nunomura H. Fujioka R.L. Russell C.S. Atwood A.B. Johnson Y. Kress H.V. Vinters M. Tabaton S. Shimohama A.D. Cash S.L. Siedlak P.L. Harris P.K. Jones R.B. Petersen G. Perry M.A. Smith Mitochondrial abnormalities in Alzheimer's disease J. Neurosci. 21 2001 3017 3023
84. M. Hirano A. Shtilbans R. Mayeux M.M. Davidson S. DiMauro J.A. Knowles E.A. Schon Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes Proc. Natl. Acad. Sci. USA 94 1997 14894 14899
85. S. Hoyer K. Oesterreich O. Wagner Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol. 235 1988 143 148
86. K. Hsiao P. Chapman S. Nilsen C. Eckman Y. Harigaya S. Younkin F. Yang G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
87. T. Hutchin G. Cortopassi A mitochondrial DNA clone is associated with increased risk for Alzheimer disease Proc. Natl. Acad. Sci. USA 92 1995 6892 6895
88. T.P. Hutchin P.R. Heath R.C. Pearson A.J. Sinclair Mitochondrial DNA mutations in Alzheimer's disease Biochem. Biophys. Res. Commun. 241 1997 221 225
89. S. Ito S. Ohta K. Nishimaki Y. Kagawa R. Soma S.Y. Kuno Y. Komatsuzaki H. Mizusawa J. Hayashi Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease Proc. Natl. Acad. Sci. USA 96 1999 2099 2103
90. B. Janetzky C. Schmid F. Bischof L. Frolich W. Gsell R.N. Kalaria P. Riederer H. Reichmann Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases Eur. Neurol. 36 1996 149 153
91. C. Janus J. Pearson J. McLaurin P.M. Mathews Y. Jiang S.D. Schmidt M.A. Chishti P. Horne D. Heslin J. French H.T. Mount R.A. Nixon M. Mercken C. Bergeron P.E. Fraser P. St. George-Hyslop D. Westaway A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
92. D.R. Johns S. Lessell N.R. Miller Molecularly confirmed Leber's hereditary optic neuropathy Neurology 41 1991 A347
93. A.B. Johnson N.R. Blum Nucleoside phosphatase activities associated with the tangles and plaques of Alzheimer's disease: A histochemical study of natural and experimental neurofibrillary tangles J. Neuropathol. Exp. Neural 29 1970 463 478
94. G.H. Kageyama M.T. Wong-Riley Histochemical localization of cytochrome oxidase in the hippocampus: Correlation with specific neuronal types and afferent pathways Neuroscience 7 1982 2337 2361
95. J. Kang H.G. Lemaire A. Unterbeck J.M. Salbaum C.L. Masters K.H. Grzeschik G. Multhaup K. Beyreuther B. Muller-Hill The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736
96. R. Katzman Alzheimer's disease N. Eng. J. Med. 314 1986 964 973
97. S.S. Kety C.F. Schmidt The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure, and normal values J. Clin. Invest. 27 1948 476 483
98. S.M. Khan D.S. Cassarino N.N. Abramova P.M. Keeney M.K. Borland P.A. Trimmer C.T. Krebs J.C. Bennett J.K. Parks R.H. Swerdlow W.D. Parker Jr. J.P. Bennett Jr. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways Ann. Neurol. 48 2000 148 155
99. M.P. King G. Attardi Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation Science 246 1989 500 503
100. M.P. King Y. Koga M. Davidson E.A. Schon Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes Mol. Cell Biol. 12 1992 480 490
101. M.P. King G. Attardi Isolation of human cell lines lacking mitochondrial DNA Methods Enzymol. 264 1996 304 313
102. S.J. Kish K. Shannak O. Hornykiewicz Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications N. Engl. J Med. 318 1988 876 880
103. S.J. Kish C. Bergeron A. Rajput S. Dozic F. Mastrogiacomo L.J. Chang J.M. Wilson L.M. DiStefano J.N. Nobrega Brain cytochrome oxidase in Alzheimer's disease J. Neurochem. 59 1992 776 779
104. S.J. Kish Brain energy metabolizing enzymes in Alzheimer's disease: Alphaketoglutarate dehydrogenase complex and cytochrome oxidase Ann. N.Y. Acad. Sci. 826 1997 218 228
105. S.J. Kish F. Mastrogiacomo M. Guttman Y. Furukawa J.W. Taanman S. Dozic M. Pandolfo J. Lamarche L. DiStefano L.J. Chang Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: A nonspecific change? J. Neurochem. 72 1999 700 707
106. S. Kosel R. Egensperger P. Mehraein M.B. Graeber No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease Biochem. Biophys. Res. Commun. 203 1994 745 749
107. E. Kraepelin Psychiatrie. Ein Lehrbuch fur Studierende and Artze. II. Band, Klinische Psychiatrie 1910 Verlag Johann Ambrosius Barth Leipzig
108. N.T. Lautenschlager L.A. Cupples V.S. Rao S.A. Auerbach R. Becker J. Burke H. Chui R. Duara E.J. Foley S.L. Glatt R.C. Green R. Jones H. Karlinsky W.A. Kukull A. Kurz E.B. Larson K. Martelli A.D. Sadovnick L. Volicer S.C. Waring J.H. Growdon L.A. Farrer Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46 1996 641 650
109. C.L. Lendon F. Ashall A.M. Goate Exploring the etiology of Alzheimer disease using molecular genetics JAMA 277 1997 825 831
110. E. Levy-Lahad W. Wasco P. Poorkaj D.M. Romano J. Oshima W.H. Pettingell C.E. Yu P.D. Jondro S.D. Schmidt K. Wang Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 1995 973 977
111. A.M. Lezza P. Mecocci A. Cormio M.F. Beal A. Cherubini P. Cantatore U. Senin M.N. Gadaleta Mitochondrial DNA 4977 by deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients FASEB J. 13 1999 1083 1088
112. F.H. Lin R. Lin H.M. Wisniewski Y.W. Hwang I. Grundke-Iqbal G. Healy-Louie K. Iqbal Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains Biochem. Biophys. Res. Commun. 182 1992 238 246
113. M.T. Lin D.K. Simon C.H. Ahn L.M. Kim M.F. Beal High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain Hum. Mol. Genet. 11 2002 133 145
114. A.W. Linnane S. Marzuki T. Ozawa M. Tanaka Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases Lancet 1 1989 642 645
115. Y. Luo J.D. Bond V.M. Ingram Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases Proc. Natl. Acad. Sci. USA 94 1997 9705 9710
116. D.M. Mann T. Iwatsubo N.J. Cairns P.L. Lantos D. Nochlin S.M. Sumi T.D. Bird P. Poorkaj J. Hardy M. Hutton G. Prihar R. Crook M.N. Rossor M. Haltia Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Abeta42(43) Ann. Neurol. 40 1996 149 156
117. R.J. Mark J.N. Keller I. Kruman M.P. Mattson Basic FGF attenuates amyloid beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+ ATPase activity in hippocampal neurons Brain Res. 756 1997 205 214
118. M.A. Martin J.A. Molina E.J. Jimenez-Jimenez J. Benito-Leon M. Orti-Pareja Y. Campos J. Arenas Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients. Grupo-Centro de Trastornos del Movimiento Neurology 46 1996 1343 1346
119. J.P. Masucci M. Davidson Y. Koga E.A. Schon M.P. King In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: Two genotypes produce similar phenotypes Mol. Cell. Biol. 15 1995 2872 2881
120. F. Mastrogiacomo C. Bergeron S.J. Kish Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease J. Neurochem. 61 1993 2007 2014
121. E. Mastrogiacomo J.G. Lindsay L. Bettendorff J. Rice S.J. Kish Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Ann. Neural. 39 1996 592 598
122. I. Maurer S. Zierz H.J. Moller A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients Neurobiol. Aging 21 2000 455 462
123. P. Mecocci U. MacGarvey M.F. Beal Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Ann. Neurol. 36 1994 747 751
124. S.W. Miller P.A. Trimmer W.D. Parker Jr. R.E. Davis Creation and characterization of mitochondrial DNA-depleted cell lines with “neuronal-like” properties J. Neurochem. 67 1996 1897 1907
125. J.A. Molina F. de Bustos F.J. Jimenez-Jimenez J. Benito-Leon T. Gasalla M. Orti-Pareja L. Vela E. Bermejo M.A. Martin Y. Campos J. Arenas Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease Neurology 48 1997 636 638
126. D. Morgan D.M. Diamond P.E. Gottschall K.E. Ugen C. Dickey J. Hardy K. Duff P. Jantzen G. DiCarlo D. Wilcock K. Connor J. Hatcher C. Hope M. Gordon G.W. Arendash A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
127. E.M. Mutisya A.C. Bowling M.E. Beal Cortical cytochrome oxidase activity is reduced in Alzheimer's disease J. Neurochem. 63 1994 2179 2184
128. Z. Nagy M.M. Esiri M. LeGris P.M. Matthews Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology Acta Neuropathol. 97 1999 346 354
129. N.J. Newman Leber's hereditary optic neuropathy. New genetic considerations Arch. Neurol. 50 1993 540 548
130. J. Ojaimi C.L. Masters C. McLean K. Opeskin P. McKelvie E. Byrne Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease Ann. Neural. 46 1999 656 660
131. W.D. Parker Jr. S.J. Boyson J.K. Parks Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann. Neurol. 26 1989 719 723
132. W.D. Parker Jr. C.M. Filley J.K Parks Cytochrome oxidase deficiency in Alzheimer's disease Neurology 40 1990 1302 1303
133. W.D. Parker Sporadic neurologic disease and the electron transport chain: A hypothesis R.M. Pascuzzi Proceedings of the 1989 Scientific Meeting of the American Society for Neurological Investigation: New Developments in Neuromuscular Disease 1990 Indiana University Printing Services Bloomington, IN
134. W.D. Parker Jr. Cytochrome oxidase deficiency in Alzheimer's disease Ann. N. Y. Acad. Sci. 640 1991 59 64
135. W.D. Parker Jr. J. Parks C.M. Filley B.K. Kleinschmidt-DeMasters Electron transport chain defects in Alzheimer's disease brain Neurology 44 1994 1090 1096
136. W.D. Parker Jr. N.J. Mahr C.M. Filley J.K. Parks D. Hughes D.A. Young C.M. Cullum Reduced platelet cytochrome c oxidase activity in Alzheimer's disease Neurology 44 1994 1086 1090
137. W.D. Parker Jr. J.K. Parks Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization Neurology 45 1995 482 486
138. C. Pereira M.S. Santos C. Oliveira Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells Neuroreport 9 1998 1749 1755
139. E.K. Perry R.H. Perry B.E. Tomlinson G. Blessed P.H. Gibson Coenzyme A acetylating enzymes in Alzheimer's disease: Possible cholinergic “compartment” of pyruvate dehydrogenase Neurosci. Lett. 18 1980 105 110
140. C. Peterson J.E. Goldman Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors Proc. Natl. Acad. Sci. USA 8 1986 2758 2762
141. V. Petruzzella X. Chen E.A. Schon Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease Biochem. Biophys. Res. Commun. 186 1992 491 497
142. J.H. Quastel Biochemistry and mental disorder Lancet 1932 1417 1419
143. X. Qiu Y. Chen M. Zhou Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease Brain Res. 893 2001 261 263
144. H. Reichmann S. Florke G. Hebenstreit H. Schrubar P. Riederer Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease J. Neurol. 240 1993 377 380
145. N.K. Robakis H.M. Wisniewski E.C. Jenkins E.A. Devine-Gage G.E. Houck X.L. Yao N. Ramakrishna G. Wolfe W.P. Silverman W.T. Brown Chromosome 21g21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome Lancet 1 1987 384 385
146. B. Rodriguez-Santiago J. Casademont V. Nunes Is there a relation between Alzheimer s disease and defects of mitochondrial DNA? Rev. Neurol. 33 2001 301 305
147. B.M. Ross J.T. Knowler J. McCulloch On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer's disease J. Neurochem. 58 1992 1810 1819
148. H. Schagger T.G. Ohm Human diseases with defects in oxidative phosphorylation. 2. FIFO ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis Eur. J. Biochem. 227 1995 916 921
149. E.A. Schon E.A. Shoubridge C.T. Moraes Cybrids in Alzheimer's disease: A cellular model of the disease? Neurology 51 1998 326 327
150. J.P. Sheehan R.H. Swerdlow S.W. Miller R.E. Davis J.K. Parks W.D. Parker J.B. Tuttle Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease J. Neurosci. 17 1997 4612 4622
151. R. Sherrington E.L. Rogaev Y. Liang E.A. Rogaeva G. Levesque M. Ikeda H. Chi C. Lin G. Li K. Holman Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
152. K.F. Shen J.C. Lai J.P Blass Pyruvate dehydrogenase phosphate (PDHb) phosphatase in brain: Activity, properties, and subcellular localization J. Neurochem. 40 1983 1366 1372
153. K.F. Sheu X. Chen E.A. Schon Are there deletions of mtochondrial DNA in Alzheimer's disease? Neurology 44 1994 A390
154. J.M. Shoffner M.D. Brown A. Torroni M.T. Lott M.F. Cabell S.S. Mirra M.F. Beal C.C. Yang M. Gearing R. Salvo Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients Genomics 17 1993 171 184
155. N.A. Simonian B.T. Hyman Functional alterations in Alzheimer's disease: Diminution of cytochrome oxidase in the hippocampal formation J. Neuropathol. Exp. Neurol. 52 1993 580 585
156. N.A. Simonian B.T. Hyman Functional alterations in Alzheimer's disease: Selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation J. Neuropathol. Exp. Neurol. 53 1994 508 512
157. 14C]glucose in vitro in human neocortex J. Neurochem. 41 1983 1329 1334
158. N.R. Sims J.M. Finegan J.P. Blass Altered glucose metabolism in fibroblasts from patients with Alzheimer's disease N. Engl. J Med. 313 1985 638 639
159. N.R. Sims J.M. Finegan J.P. Blass D.M. Bowen D. Neary Mitochondrial function in brain tissue in primary degenerative dementia Brain Res 436 1987 30 38
160. N.R. Sims J.M. Finegan J.P. Blass Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease Ann. Neural 21 1987 451 457
161. M.A. Smith K.L. Drew A. Nunomura A. Takeda K. Hirai X. Zhu C.S. Atwood A.K. Raina C.A. Rottkamp L.M. Sayre R.P. Friedland G. Perry Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: The chickens or the eggs? Neurochem. Int. 40 2002 527 531
162. S. Sorbi E.D. Bird J.P. Blass Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain Ann. Neural. 13 1983 72 78
163. S. Sorbi S. Piacentini S. Latorraca P. Piersanti L. Amaducci Alterations in metabolic properties in fibroblasts in Alzheimer disease Alzheimer Dis. Assoc. Disord. 9 1995 73 77
164. R.H. Swerdlow J.K. Parks D.S. Cassarino D.J. Maguire R.S. Maguire J.P. Bennett Jr. R.E. Davis W.D. Parker Jr. Cybrids in Alzheimer's disease: A cellular model of the disease? Neurology 49 1997 918 925
165. R.H. Swerdlow Role of Mitochondria in Parkinson's Disease M.R Chesselet Molecular Mechanisms of Neurodegenerative Diseases 2000 Humana Press Inc New Jersey 233 270
166. R.H. Swerdlow Mitochondrial DNA-related mitochondrial dysfunction in neurodegenerative diseases Arch. Pathol. Lab. Med. 126 2002 271 280
167. A. Takeuchi M.C. Irizarry K. Duff T.C. Saido K Hsiao Ashe M. Hasegawa D.M. Mann B.T. Hyman T Iwatsubo Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss Am. J. Pathol. 157 2000 331 339
168. M. Tanaka S.A. Kovalenko J.S. Gong H.J. Borgeld K. Katsumata M. Hayakawa M. Yoneda T. Ozawa Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases Ann. NY Acad. Sci. 786 1996 102 111
169. Y. Tanno K. Okuizumi S. Tsuji mtDNA polymorphisms in Japanese sporadic Alzheimer's disease Neurobiol. Aging 19 1998 S47 S51
170. R.E. Tanzi J.F. Gusella P.C. Watkins G.A. Bruns P. St. George-Hyslop M.L. Van Keuren D. Patterson S. Pagan D.M. Kurnit R.L. Neve Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus Science 235 1987 880 884
171. P.A. Trimmer R.H. Swerdlow J.K. Parks P. Keeney J.P. Bennett Jr. S.W. Miller R.E. Davis W.D. Parker Jr. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines Exp. Neural. 162 2000 37 50
172. J. Valla J.D. Berndt F. Gonzalez-Lima Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: Superficial laminar cytochrome oxidase associated with disease duration J. Neurosci. 21 2001 4923 4930
173. A.J. Van Zuylen G.J. Bosman W. Ruitenbeek P.J. Kal Kalmthout W.J. De Grip No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease Neurology 42 1992 1246 1247
174. R.W. Verwer K.A. Jansen A.A. Sluiter C.W. Pool W. Kamphorst D.F. Swaab Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits Exp. Neural. 163 2000 440 451
175. D.C. Wallace J.H. Ye S.N. Neckelmann G. Singh K.A. Webster B.D. Greenberg Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: Mitochondrial DNA genes sustain seventeen times more mutations Curr. Genet. 12 1987 81 90
176. D.C. Wallace Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256 1992 628 632
177. D.C. Wallace Mitochondrial DNA sequence variation in human evolution and disease Proc. Natl. Acad. Sci. USA 91 1994 8739 8746
178. D.C. Wallace C. Stugard D. Murdock T. Schutt M.D. Brown Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations Proc. Natl. Acad. Sci. USA 94 1997 14900 14905
179. M.T. Webster B.R. Pearce D.M. Bowen P.T. Francis The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells J. Neural. Transm. 105 1998 839 853
180. H. Wisniewski R.D. Terry A. Hirano Neurofibrillary pathology J. Neuropathol. Exp. Neurol. 29 1970 163 176
181. M.T. Wong-Riley Cytochrome oxidase: An endogenous metabolic marker for neuronal activity Trends Neurosci. 12 1989 94 101
182. M. Wong-Riley P. Antuono K.C. Ho R. Egan R. Hevner W. Liebl Z. Huang R. Rachel J. Jones Cytochrome oxidase in Alzheimer's disease: Biochemical, histochemical, and immunohistochemical analyses of the visual and other systems Vision Res 37 1997 3593 3608
183. M.A. Wragg C.J. Talbot J.C. Morris C.L. Lendon A.M. Goate No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant Neurosci. Lett. 201 1995 107 110
184. C.M. Yates J. Butterworth M.C. Tennant A. Gordon Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias J. Neurochem. 55 1990 1624 1630
185. G. Zsurka J. Kalman A. Csaszar I. Rasko Z. Janka P. Venetianer No mitochondrial haplotype was found to increase risk for Alzheimer's disease Biol. Psychiatry 44 1998 371 373